Avanos Medical (AVNS) Depreciation & Amortization (CF) (2016 - 2024)
Historic Depreciation & Amortization (CF) for Avanos Medical (AVNS) over the last 12 years, with Q4 2024 value amounting to $11.1 million.
- Avanos Medical's Depreciation & Amortization (CF) fell 347.83% to $11.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $45.5 million, marking a year-over-year decrease of 130.15%. This contributed to the annual value of $45.5 million for FY2024, which is 130.15% down from last year.
- Latest data reveals that Avanos Medical reported Depreciation & Amortization (CF) of $11.1 million as of Q4 2024, which was down 347.83% from $11.7 million recorded in Q3 2024.
- Avanos Medical's Depreciation & Amortization (CF)'s 5-year high stood at $13.4 million during Q4 2022, with a 5-year trough of $9.5 million in Q2 2021.
- Moreover, its 5-year median value for Depreciation & Amortization (CF) was $11.1 million (2022), whereas its average is $11.0 million.
- In the last 5 years, Avanos Medical's Depreciation & Amortization (CF) skyrocketed by 4105.26% in 2022 and then plummeted by 1417.91% in 2023.
- Over the past 5 years, Avanos Medical's Depreciation & Amortization (CF) (Quarter) stood at $10.8 million in 2020, then dropped by 12.04% to $9.5 million in 2021, then soared by 41.05% to $13.4 million in 2022, then dropped by 14.18% to $11.5 million in 2023, then dropped by 3.48% to $11.1 million in 2024.
- Its Depreciation & Amortization (CF) was $11.1 million in Q4 2024, compared to $11.7 million in Q3 2024 and $11.3 million in Q2 2024.